Current therapeutic options for low-risk papillary thyroid carcinoma: A scoping evidence review

被引：10

作者：

Sanabria, Alvaro ^{[1
,2
]}

Pinillos, Pilar ^{[3
]}

Lira, Renan B. ^{[4
]}

Shah, Jatin P. ^{[5
,6
]}

Tufano, Ralph P. ^{[7
]}

Zafereo, Mark E. ^{[8
]}

Nixon, Iain J. ^{[9
]}

Randolph, Gregory W. ^{[10
]}

Simo, Ricard ^{[11
]}

Vander Poorten, Vincent ^{[12
,13
]}

Rinaldo, Alessandra ^{[14
]}

Medina, Jesus E. ^{[15
]}

Khafif, Avi ^{[16
]}

Angelos, Peter ^{[17
,18
]}

Makitie, Antti A. ^{[19
,20
]}

Shaha, Ashok R. ^{[5
]}

Rodrigo, Juan P. ^{[21
,22
,23
]}

Hartl, Dana M. ^{[24
,25
]}

Kowalski, Luiz P. ^{[4
,26
]}

Ferlito, Alfio ^{[27
]}

机构：

[1] Univ Antioquia, Dept Surg, Sch Med, IPS Univ,Hosp Univ San Vicente Fdn, Medellin, Colombia

[2] CEXCA Ctr Excelencia Enfermedades Cabeza & Cuello, Clin Vegas Grp Quironsalud, Medellin, Colombia

[3] Univ Nacl Colombia, Dept Surg, Sch Med, Hosp Univ Nacl Colombia, Bogota, Colombia

[4] AC Camargo Canc Ctr, Head & Neck Surg & Otorhinolaryngol Dept, Sao Paulo, Brazil

[5] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA

[6] Sechenov Univ, Dept Oncol Radiotherapy & Plast Surg, Moscow, Russia

[7] Sarasota Mem Hlth Care Syst, FPG Thyroid & Parathyroid Ctr, Div Head & Neck Endocrine Surg, Sarasota, FL USA

[8] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA

[9] Edinburgh Royal Infirm, Dept Otorhinolaryngol Head & Neck Surg, Edinburgh, Midlothian, Scotland

[10] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Thyroid Surg Oncol, Thyroid Parathyroid Endocrine Surg Div, Boston, MA 02115 USA

[11] Kings Coll London, Dept Otorhinolaryngol Head & Neck Surg, Guys & St Thomas Hosp NHS Fdn Trust, London, England

[12] Univ Hosp Leuven, Otorhinolaryngol Head & Neck Surg, Leuven, Belgium

[13] Katholieke Univ Leuven, Dept Oncol, Sect Head & Neck Oncol, Leuven, Belgium

[14] Univ Udine, Sch Med, Udine, Italy

[15] Univ Oklahoma, Coll Med, Dept Otolaryngol & Head & Neck Surg, Oklahoma City, OK 73190 USA

[16] Assuta Med Ctr, Head & Neck Surg & Oncol Unit, ARM Ctr Adv Otolaryngol Head & Neck Surg, Tel Aviv, Israel

[17] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA

[18] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA

[19] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland

[20] Helsinki Univ Hosp, Helsinki, Finland

[21] Hosp Univ Cent Asturias ISPA, Dept Otolaryngol, Oviedo, Spain

[22] Univ Oviedo IUOPA, Oviedo, Spain

[23] CIBERONC, Head & Neck Canc Unit, Madrid, Spain

[24] Inst Gustave Roussy, Dept Otolaryngol Head & Neck Surg, Villejuif, France

[25] Lab Phonet & Phonol, Paris, France

[26] Univ Sao Paulo, Sch Med, Dept Head & Neck Surg, Sao Paulo, Brazil

[27] Int Head & Neck Sci Grp, Padua, Italy

来源：

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2022年 / 44卷 / 01期

关键词：

ablation; papillary carcinoma; surgery; surveillance; thyroid carcinoma; treatment; AXILLO-BREAST APPROACH; CONVENTIONAL OPEN THYROIDECTOMY; VIDEO-ASSISTED THYROIDECTOMY; QUALITY-OF-LIFE; ROBOTIC THYROIDECTOMY; ENDOSCOPIC THYROIDECTOMY; ACTIVE SURVEILLANCE; MICROWAVE ABLATION; RADIOFREQUENCY ABLATION; SURGICAL COMPLETENESS;

D O I：

10.1002/hed.26883

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Most cases of thyroid carcinoma are classified as low risk. These lesions have been treated with open surgery, remote access thyroidectomy, active surveillance, and percutaneous ablation. However, there is lack of consensus and clear indications for a specific treatment selection. The objective of this study is to review the literature regarding the indications for management selection for low-risk carcinomas. Systematic review exploring inclusion and exclusion criteria used to select patients with low-risk carcinomas for treatment approaches. The search found 69 studies. The inclusion criteria most reported were nodule diameter and histopathological confirmation of the tumor type. The most common exclusions were lymph node metastasis and extra-thyroidal extension. There was significant heterogeneity among inclusion and exclusion criteria according to the analyzed therapeutic approach. Alternative therapeutic approaches in low-risk carcinomas can be cautiously considered. Open thyroidectomy remains the standard treatment against which all other approaches must be compared.

引用

页码：226 / 237

页数：12

共 86 条

[51] Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center [J].